Rise in number of diagnostic centers and hospitals, technological advancements, increase in awareness and acceptance of personalized medicine drives the polymerase chain reaction technologies market 

Polymerase chain reaction technologies are medical devices used to generate thousands to millions of copies of a piece of deoxyribonucleic acid (DNA). These devices are commonly used in various life science fields such as genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics.

Get the sample report: https://www.alliedmarketresearch.com/request-sample/1625?utm_source=openpr_Niranjan

According to a new report published by Allied Market Research, titled, Polymerase Chain Reaction Technologies Market by Technology, Products, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the polymerase chain reaction technologies market accounted for $7,027 million in 2016, and is estimated to reach $10,776 million by 2023, registering a CAGR of 6.2% from 2017 to 2023. North America is the highest contributor in the polymerase chain reaction technologies market; however, Asia-Pacific is expected to witness the highest growth rate.

PCR techniques have the most potential features such as absolute detection and quantification of genetic materials such as DNA and RNA that are increasingly being used in life sciences research and molecular diagnostics. The device can be used quantify and analyze rare alleles and point mutations.

Purchase report @Discount: https://www.alliedmarketresearch.com/checkout/554782?utm_source=openpr_Niranjan

Advanced PCR systems are being developed with enhanced capabilities such as a broad menu of tests, higher sensitivity, and specificity. Other major advances related with the PCR are shorter PCR cycling time, higher productivity, and automated workflow.

The advancement in the technology of qPCR and dPCR leading to automation, improved accuracy, and enhanced sensitivity majorly drive the market growth. These products provide a high level of efficiency and productivity in research and drug discovery and reduce the time required for the novel drug development. In addition, there is increased demand for polymerase chain reaction technologies owing to the increase in the number of hospitals and research centers.

Furthermore, the increase in the number of patients suffering from infectious diseases and rise in funding in gene therapy and human genome projects will also help to fuel the growth of the global polymerase chain reaction technologies market. Moreover, there is growth in demand for polymerase chain reaction technologies in the field of life science, clinical diagnostics, and others, which would further drive the market. However, the growth of non-validated homebrew test and unstable reimbursement policies are projected to hinder the growth of global polymerase chain reaction technologies market.

The report segments the market by product, technology, end user, application, and geography. In terms of technology, it is bifurcated into quantitative PCR and digital PCR. By product, it is classified into instruments, reagents, and consumables. Based on application, it is categorized into clinical, research, and forensic applications. On the basis of an end user, it is divided into diagnostic centers & hospitals, forensic laboratories, biotech & pharma companies, and academic & research institutions. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The real-time PCR segment is the major contributor towards the global PCR market in 2016, due to several factors including the increase in the use of qPCR in research and medical diagnostics, technological advancements, growing use of robotics for lab automation, and expansion of the installed base.

Among the end-users, academic & research institutions occupied the major share of the PCR instrument market due to increased test volume of infectious diseases and various types of cancers.

In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the rise in the prevalence of infectious diseases and cancer in this region and technological advancement in PCR. However, Asia is projected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities.

Key Findings of the Polymerase Chain Reaction Technologies Market:
• Digital PCR segment is projected to grow at the highest rate during the analysis period.
• Reagents and consumables segment was the highest revenue-generating segment in 2016 and is expected to continue its dominance in future.
• North America dominated global polymerase chain reaction technologies market in 2016 and is projected to continue its dominance in the future.
• China is expected to grow highest in the Asia-Pacific region during the forecast period.
• Services segment was the largest contributor among the products and services segments.

Key players operating in the market are Thermo Fisher Scientific Inc., Sygnis AG, LGC Ltd, Bio-Rad Laboratories Inc., Agilent Technologies, Inc., BioMerieux S.A., RainDance Technologies, Inc., Affymetrix Inc., Fluidigm Corporation, and Takara Bio Inc.

Other prominent players in the value chain include Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, Fluidigm, GE Healthcare, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, and Siemens Healthcare.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.